Unknown

Dataset Information

0

Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients.


ABSTRACT: Natalizumab and fingolimod are effective multiple sclerosis (MS) therapies that disrupt lymphocyte migration but have differential effects on B cell maturation and trafficking. We investigated their effects on peripheral blood (PB) and cerebrospinal fluid (CSF) B cell repertoires using next-generation deep sequencing. Paired CSF and PB B cell subsets (naïve, CD27+ memory, and CD27-IgD- double-negative B cells and plasmablasts) were collected by applying flow cytometry at baseline and after 6 months of treatment and their respective heavy-chain variable region repertoires assessed by Illumina MiSeq. Treatment with fingolimod contracted, whereas natalizumab expanded circulating PB B cells. CSF B cell numbers remained stable following fingolimod treatment but decreased with natalizumab therapy. Clonal overlap between CSF and PB B cells was reduced with natalizumab treatment but remained stable with fingolimod therapy. Lineage analyses of pre- and posttreatment CSF B cell repertoires revealed large, clonally expanded B cell clusters in natalizumab-treated MS patients but no intrathecal clonal expansion following fingolimod therapy. Our findings suggest that natalizumab diminishes the exchange of peripheral and intrathecal B cells without impacting intrathecal clonal expansion. In contrast, fingolimod treatment fails to alter blood-brain barrier B cell exchange but diminishes intrathecal clonal expansion. Sphingosine-1 phosphate receptor inhibition may alter intrathecal B cell biology in MS.

SUBMITTER: Kowarik MC 

PROVIDER: S-EPMC8116403 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8804113 | biostudies-literature
| S-EPMC6389745 | biostudies-literature
| S-EPMC7480919 | biostudies-literature
| S-EPMC6784753 | biostudies-literature
| S-EPMC7007466 | biostudies-literature
| S-EPMC5497532 | biostudies-other
| S-EPMC8596196 | biostudies-literature
| S-EPMC4011812 | biostudies-other
| S-EPMC8419322 | biostudies-literature
2024-01-31 | GSE250453 | GEO